Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hantavirus envelope glycoproteins Gn and Gc are membrane-anchored proteins expressed from the viral M segment as a GPC precursor that is cleaved into mature forms[4][5]. Gn and Gc assemble as heterodimers, which further organize into tetrameric spike complexes on the viral envelope, creating a lattice structure that decorates the virion surface[1][2][5]. These glycoproteins are essential for viral entry—Gn/Gc mediates host cell recognition, endocytosis, and Gc specifically mediates the fusion of the viral and endosomal membranes at acidic pH during cell entry[2][3][5]. Gc is classified as a class II fusion protein, undergoing substantial conformational changes to expose fusion peptides and enable membrane fusion[2][3][5]. The spike complexes formed by Gn/Gc are major targets of neutralizing antibodies, which can prevent infection by blocking glycoprotein function[1][5]. Beyond entry, the cytoplasmic tails of Gn and Gc play a critical role in virion assembly and budding by interacting with the viral nucleoprotein and other assembly components[3][4]. There are currently no clinically approved drugs specifically targeting Gn or Gc, but multiple investigational monoclonal antibodies and viral entry inhibitors are being explored as potential therapeutics.
Neutralizing antibodies block glycoprotein function to prevent virus entry; Fusion inhibitors stabilize prefusion state or block conformational change of Gc; Small molecules or peptides may disrupt glycoprotein assembly, fusion, or receptor binding (experimental)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hantavirus envelope glycoprotein Gn and Gc (Gn and Gc).